Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

AGIO holding history

Agios Pharmaceuticals, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AGIO overviewAll 13F holders of AGIOFull Q2 2026 holdings

Shares (Q2 2026)
9,694
Value
$359.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AGIO by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,694$359.7K<0.1%−1,111−10.3%ReducedHolders
Q1 202610,805$365.5K<0.1%−2,092−16.2%ReducedHolders
Q4 202512,897$351.1K<0.1%+1,169+10.0%AddedHolders
Q3 202511,728$470.8K<0.1%−2,016−14.7%ReducedHolders
Q2 202513,744$457.1K<0.1%−1,077−7.3%ReducedHolders
Q1 202514,821$434.3K<0.1%−3,798−20.4%ReducedHolders
Q4 202418,619$611.8K<0.1%+4,577+32.6%AddedHolders
Q3 202414,042$623.9K<0.1%+3,098+28.3%AddedHolders
Q2 202410,944$471.9K<0.1%−2,973−21.4%ReducedHolders
Q1 202413,917$406.9K<0.1%+1,152+9.0%AddedHolders
Q4 202312,765$284.3K<0.1%+1,905+17.5%AddedHolders
Q3 202310,860$268.8K<0.1%+39+0.4%AddedHolders
Q2 202310,821$306.5K<0.1%+565+5.5%AddedHolders
Q1 202310,256$235.6K<0.1%−1,310−11.3%ReducedHolders
Q4 202211,566$324.8K<0.1%+937+8.8%AddedHolders
Q3 202210,629$300.0K<0.1%−677−6.0%ReducedHolders
Q2 202211,306$251.0K<0.1%−5,770−33.8%ReducedHolders
Q1 202217,076$497.0K<0.1%−3,806−18.2%ReducedHolders
Q4 202120,882$687.0K<0.1%−664−3.1%ReducedHolders
Q3 202121,546$994.0K<0.1%−7,348−25.4%ReducedHolders
Q2 202128,894$1.59M<0.1%+18,177+169.6%AddedHolders
Q1 202110,717$553.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.